2022
Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
Mello MM, Opel DJ, Benjamin RM, Callaghan T, DiResta R, Elharake JA, Flowers LC, Galvani AP, Salmon DA, Schwartz JL, Brewer NT, Buttenheim AM, Carpiano RM, Clinton C, Hotez PJ, Lakshmanan R, Maldonado YA, Omer SB, Sharfstein JM, Caplan A. Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA. The Lancet 2022, 400: 535-538. PMID: 35817078, PMCID: PMC9270060, DOI: 10.1016/s0140-6736(22)00875-3.Peer-Reviewed Original ResearchCOVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on reddit
Kumar N, Corpus I, Hans M, Harle N, Yang N, McDonald C, Sakai SN, Janmohamed K, Chen K, Altice FL, Tang W, Schwartz JL, Jones-Jang SM, Saha K, Memon SA, Bauch CT, Choudhury M, Papakyriakopoulos O, Tucker JD, Goyal A, Tyagi A, Khoshnood K, Omer S. COVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on reddit. BMC Public Health 2022, 22: 446. PMID: 35255881, PMCID: PMC8899002, DOI: 10.1186/s12889-022-12824-7.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccine perceptionsVaccine perceptionsCOVID-19 vaccination servicesVaccine trial dataUS vaccineDevelopment of interventionsVaccine trialsVaccination servicesObservational studyVaccine informationTrial dataVaccineConclusionsOur findingsVaccine-related keywordsCOVID-19Vaccine misinformationEarly phaseInitial phaseAssociationFurther researchCommunication campaignsVaccinationResultsTherePrevalenceMethodsWeUnderstanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework
Ellingson MK, Bednarczyk RA, O’Leary S, Schwartz JL, Shapiro ED, Niccolai LM. Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework. Journal Of Behavioral Medicine 2022, 46: 356-365. PMID: 35194726, PMCID: PMC8862696, DOI: 10.1007/s10865-022-00296-4.Peer-Reviewed Original Research
2021
Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
Egilman A, Wallach JD, Puthumana J, Zhang AD, Schwartz JL, Ross JS. Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration. Journal Of General Internal Medicine 2021, 36: 3281-3284. PMID: 34131876, PMCID: PMC8205312, DOI: 10.1007/s11606-021-06943-x.Peer-Reviewed Original ResearchSpeed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration
Puthumana J, Egilman AC, Zhang AD, Schwartz JL, Ross JS. Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration. JAMA Internal Medicine 2021, 181: 559-560. PMID: 33170923, PMCID: PMC7656319, DOI: 10.1001/jamainternmed.2020.7472.Peer-Reviewed Original ResearchDemographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020
Zhang AD, Puthumana J, Egilman AC, Schwartz JL, Ross JS. Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020. Journal Of General Internal Medicine 2021, 37: 700-702. PMID: 33660209, PMCID: PMC7928194, DOI: 10.1007/s11606-021-06670-3.Peer-Reviewed Original Research
2018
Costs, Consequences, and Policy Responses of Vaccine-Preventable Disease Outbreaks
Schwartz JL. Costs, Consequences, and Policy Responses of Vaccine-Preventable Disease Outbreaks. JAMA Pediatrics 2018, 172: 805-807. PMID: 30073255, DOI: 10.1001/jamapediatrics.2018.2238.Peer-Reviewed Original Research
2017
Vaccines and the Trump Administration-Reasons for Optimism Amid Uncertainty.
Schwartz JL. Vaccines and the Trump Administration-Reasons for Optimism Amid Uncertainty. American Journal Of Public Health 2017, 107: 1892-1893. PMID: 29048968, PMCID: PMC5678397, DOI: 10.2105/ajph.2017.304111.Peer-Reviewed Original ResearchUsing campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights
Nowak GJ, Shen AK, Schwartz JL. Using campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights. Vaccine 2017, 35: 5543-5550. PMID: 28886947, DOI: 10.1016/j.vaccine.2017.08.064.Peer-Reviewed Original ResearchConceptsAdult vaccinationAdult vaccinesSocial psychological notionHealthcare providersAdult immunization ratesPsychological notionsPsychological valueRecommended vaccinationsHealth communication literatureImmunization ratesIntegrative reviewCommunication literatureVaccinationValue perceptionsAdult HealthVaccineCommunication campaignsOverall usePerceptionPublic healthGreater supportUnited StatesHealthProvidersAssessment
2016
Vaccine Pricing and US Immunization Policies
Schwartz JL. Vaccine Pricing and US Immunization Policies. JAMA 2016, 316: 226-226. PMID: 27404201, DOI: 10.1001/jama.2016.6307.Peer-Reviewed Original Research
2012
Immune to addiction: the ethical dimensions of vaccines against substance abuse
Young MJ, Sisti DA, Rimon-Greenspan H, Schwartz JL, Caplan AL. Immune to addiction: the ethical dimensions of vaccines against substance abuse. Nature Immunology 2012, 13: 521-524. PMID: 22610239, DOI: 10.1038/ni.2321.Peer-Reviewed Original Research
2011
Vaccination Refusal: Ethics, Individual Rights, and the Common Good
Schwartz JL, Caplan AL. Vaccination Refusal: Ethics, Individual Rights, and the Common Good. Primary Care Clinics In Office Practice 2011, 38: 717-728. PMID: 22094142, DOI: 10.1016/j.pop.2011.07.009.Peer-Reviewed Original ResearchConceptsDoctor-patient relationshipEthical considerationsApparent recent increaseCommon goodHealth care providersIndividual rightsPublic healthVaccination recommendationsVaccination scheduleVaccination programCare providersVaccine refusalPossible responsesOutright resistanceEthicsParental attitudesHealthRightsPatientsRefusalVaccinePhysiciansGoods